Clinical Trials Directory

Trials / Conditions / Double Expressor Lymphoma

Double Expressor Lymphoma

8 registered clinical trials studyying Double Expressor Lymphoma — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in th
NCT07069699
National Cancer Institute (NCI)Phase 1 / Phase 2
Not Yet RecruitingA Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance
NCT07511114
Ruijin HospitalPhase 3
RecruitingRLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL
NCT06674096
Zhejiang Cancer HospitalPhase 2
Not Yet RecruitingMechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BC
NCT06652152
Ruijin Hospital—
RecruitingLoncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large
NCT05600686
Joseph TuscanoPhase 2
Active Not RecruitingPolatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma
NCT04479267
Barbara Ann Karmanos Cancer InstitutePhase 2
Active Not RecruitingTesting the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lympho
NCT03984448
National Cancer Institute (NCI)Phase 2 / Phase 3
CompletedLenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma P
NCT04164368
Fudan UniversityPhase 2